Study blood clot cell activity in people with a heart pump
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study looks at how your blood’s clot-forming cells (platelets) behave when you have a heart pump device placed (short-term or long-term). The results may help doctors better understand complications and how to manage them after implantation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You are planning to get a heart pump device placed soon (short-term or long-term)
- You may be getting a short-term device such as Impella or ECMO
- Or you may be getting a long-term device such as an LVAD
- You agree to take part in the study (consent)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines how blood clotting cells (platelets) behave when patients are on a heart-lung support machine called ECMO. Researchers will take small blood samples to understand if the machine affects platelet function and how to manage blood thinning medication safely.
This study tests whether patients with an artificial heart pump (CH-VAD) can safely stop taking aspirin after surgery. Aspirin is often given to prevent blood clots, but this trial wants to see if it's really necessary for this specific pump.
This trial tests if taking aspirin along with a standard blood thinner helps people with a HeartMate3 heart pump have fewer bleeding or clotting problems. It is for people who have had their pump for at least 3 months.
This study looks at patients who have a blood clot on the device placed in the heart to close off a small pouch (left atrial appendage). It aims to understand why these clots happen and how to manage them.
This study watches how well platelets (cells that help blood clot) work in people who have high-risk heart surgery using a heart-lung machine for more than 2 hours. The goal is to learn more about bleeding risks after surgery.
This study examines how heart-lung machines used during heart surgery affect blood platelets (clotting cells) and the body's inflammatory response. Understanding these changes may help doctors better manage bleeding and inflammation after cardiac surgery.
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.